|
Variables
|
Univariate
|
Multivariate
| |
|---|
|
HR (95% CI)
|
P value
|
HR (95% CI)
|
P value
|
|---|
|
Age (year)
| | | | |
|
≤ 60
|
Reference
| | | |
|
> 60
|
0.610 (0.450, 0.826)
|
0.001
|
0.643 (0.454, 0.911)
|
0.013
|
|
Sex
| | | | |
|
Female
|
Reference
| | | |
|
Male
|
0.992 (0.798, 1.233)
|
0.942
|
0.916 (0.721, 1.165)
|
0.475
|
|
BMI (kg/m2)
| | | | |
|
< 28
|
Reference
| | | |
|
≥ 28
|
1.049 (0.751, 1.466)
|
0.778
|
1.155 (0.817, 1.631)
|
0.415
|
|
Hypertension
| | | | |
|
No
|
Reference
| | | |
|
Yes
|
0.743 (0.549, 1.006)
|
0.055
|
0.905 (0.646, 1.269)
|
0.564
|
|
Diabetes
| | | | |
|
No
|
Reference
| | | |
|
Yes
|
0.764 (0.515, 1.134)
|
0.181
|
0.869 (0.561, 1.346)
|
0.528
|
|
Lymphocytes
| | | | |
|
No decreased
|
Reference
| | | |
|
Decreased
|
0.885 (0.698, 1.123)
|
0.316
| | |
|
ALT (U/L)
| | | | |
|
≤ 40
|
Reference
| | | |
|
> 40
|
1.057 (0.801, 1.396)
|
0.696
| | |
|
LDH (U/L)
| | | | |
|
≤ 250
|
Reference
| | | |
|
> 250
|
0.870 (0.697, 1.086)
|
0.217
|
0.935 (0.722, 1.210)
|
0.607
|
|
ALB (g/L)
| | | | |
|
> 35
|
Reference
| | | |
|
≤ 35
|
0.774 (0.557, 1.075)
|
0.126
| | |
|
D-dimer (mg/L)
| | | | |
|
≤ 0.5
|
Reference
| | | |
|
> 0.5
|
0.857 (0.625, 1.176)
|
0.340
| | |
|
Atomized inhalation of interferon α-2b
| | | | |
|
No
|
Reference
| | | |
|
Yes
|
1.355 (1.088, 1.688)
|
0.007
|
1.357 (1.050, 1.755)
|
0.020
|
|
Lopinavir/ritonavir treatment
| | | | |
|
No
|
Reference
| | | |
|
Yes
|
0.993 (0.771, 1.279)
|
0.957
| | |
- PCR polymerase chain reaction, ALT alanine transaminase, LDH lactate dehydrogenase, ALB albumin
